PPARG and hepatocellular carcinoma: Recently, Afaloniati et al., confirmed in a HCC murine model, that treatment with romidepsin, an HDACs inhibitor, can modulate the translocation of PPARγ to the nucleus, proposing this transcriptional factor as a possible anti-inflammatory mediator [25].